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Pancreatic islet transplantation may successfully re-
store normoglycemia in type 1 diabetic patients. How-
ever, successful grafting requires transplantation of a
sufficient number of islets, usually requiring two or
more donors. During the isolation process and following
clinical transplantation, islets are subjected to severe
adverse conditions that impair survival and ultimately
contribute to graft failure. Here, we have mapped the
major intracellular stress-signaling pathways that may
mediate human islet loss during isolation and following
cytokine attack. We found that the isolation procedure
potently recruits two pathways consisting of mitogen-
activated protein kinase kinase (MKK)7 3 Jun NH2-
terminal kinase (JNK)/p38 3 c-fos and the nuclear
factor-B (NF-B) 3 iNOS module. Cytokines activate
the NF-B 3 iNOS and MKK4/MKK3/6 3 JNK/p38
pathways without recruitment of c-fos. Culturing the
islets for 48 h after isolation allows for the activated
pathways to return to background levels, with expres-
sion of MKK7 becoming undetectable. These data indi-
cate that isolation and cytokines recruit different death
pathways. Therefore, strategies might be rationally de-
veloped to avoid possible synergistic activation of these
pathways in mediating islet loss during isolation and
following grafting. Diabetes 53:2815–2823, 2004
Type 1 diabetes is an autoimmune disease result-ing from a progressive decrease in -cell massand function (1). The mediators of -cell dys-function and destruction include macrophages,
T-cells and their inflammatory products, such as cytokines
(2), and free radicals such as nitric oxide (NO) (3–5).
Pancreatic islet transplantation is one strategy that holds
promise to cure patients with type 1 diabetes (6), but
purified pancreatic islet grafts have failed to maintain
long-term glucose homeostasis in human recipients; the
reasons for this failure are still poorly understood (7,8).
There is however a more immediate problem with islet
grafting that is dependent on poor islet recovery from
donors (9) and early islet loss following the first hours of
grafting (10,11). This tendency of islet grafts to fail to
function within a short period after transplantation is
termed primary graft nonfunction (PNF). Indeed, the islet
isolation procedure itself destroys cellular and noncellular
components of the pancreas that probably play a role in
supporting islet survival (10,12). Further islet transplanta-
tion exposes cells to a variety of stressful stimuli, notably
proinflammatory cytokines that encourage -cell death
and lead to early graft failure (13–15). Regardless of the
molecular mechanisms involved, a reduction in islet -cell
mass after transplantation implicates islet -cell death by
apoptosis and the prerecruitment of intracellular death-
signaling pathways (16,17).
Death-signaling pathways that have been shown to
contribute to -cell death in vitro include the transcription
factor nuclear factor-B (NF-B) (17) and the stress group
of the mitogen-activated protein kinases (MAPKs) (18,19),
and pharmacological inhibition of these pathways has
proven beneficial in different models of insulin-secreting
cell death in vitro (20,21). NF-B is a ubiquitously ex-
pressed transcription factor that regulates a family of
inducible genes (22). At rest, NF-B is found in the cytosol
in an inactive form bound to the inhibitory protein inhib-
itor of B (IB) (23). Cytokines and other stresses induce
the phosphorylation of IB, which then undergoes deg-
radation, releasing NF-B that translocates into the nu-
cleus (24). One of the major genes upregulated by NF-B
in rodent islets and that contributes to apoptosis is the
inducible NO synthase (iNOS) gene. Regulation and acti-
vation of MAPKs appear to require more signaling events.
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MAPK core module pathways are composed of three
conserved kinases that proceed through a phosphorylation
cascade, creating a sequential-activation pathway (25).
The first kinase in the module is an MAPK kinase kinase,
a serine/threonine kinase that, when activated, phosphor-
ylates and activates the next kinase in the module, an
MAPK kinase (MKK). The MKKs are dual-specific kinases
that phosphorylate a Thr-X-Tyr motif in the activation loop
of MAPKs. MAPKs are the final kinases in the module and
phosphorylate different substrates on serine and threonine
residues (26,27). Three major conserved groups of MAPKs
have been described: the extracellular signal–regulated
kinases (ERKs; ERK1/2/3) (28), the p38 kinases (p38
///) (29), and the c-Jun NH2-terminal kinases (JNKs;
JNK1/2/3) (30). In mammals, these MAPKs can be acti-
vated by six MKKs: MKK1 and -2 are upstream activators
of ERK1/2 (31), MKK3 and -6 are activators of p38 (32–34),
and MKK4 and -7 regulate JNK (35,36). It has also been
shown that MKK4 can activate p38 in addition to JNK (37).
Multiple stresses, including ultraviolet and  irradiation,
cytotoxic drugs, cold and heat shocks, loss of survival
factors, hypo- and hyperosmolarity, proinflammatory cy-
tokines, shearing stresses, and reactive oxygen species
(38,39), can similarly lead to both JNK and p38 activation,
hence the name “stress kinases.” Both JNK and p38
activate downstream nuclear transcription factors that
participate to the cellular response (40,41). Among these,
activation of the activator protein-1, which is formed of
heteromers of c-Fos, c-Jun, and ATF2, is required for some
forms of apoptosis, notably in neuronal cells (42,43). A
major transcriptional target of JNK and p38 is the c-fos
gene.
During the isolation procedure and immediately follow-
ing grafting, human islets are exposed to diverse stressful
stimuli that lead to islet damage. The goal of this study is
to provide a map of the recruitment of the aforementioned
stress-signaling pathways that could participate in the
dysfunction and destruction of human islets during isola-
tion and following acute cytokine attack.
RESEARCH DESIGN AND METHODS
Human islet isolation. The abdominal organs from a cadaveric donor are
perfused with University of Wisconsin preservation solution at 4°C and the
pancreas removed. The current techniques for isolating islets require that
pancreata stored in cold University of Wisconsin solution be processed within
12 h in order to prevent islet deterioration. Additional storage using the
two-layer cold storage method (TLM; “pancreas” step), which uses University
of Wisconsin solution and perfluorochemical, extends the acceptable preser-
vation period of pancreata before islet isolation and increases islet yields.
Thus, after the pancreas is trimmed of extra tissue and the main pancreatic
duct cannulated, the pancreas is stored at 8°C for an additional 3 h on TLM.
Islet isolation is performed as described in the method of Ricordi et al. (44),
which combines enzymatic digestion and mechanical dissociation. Briefly,
after injection of an enzyme solution (Liberase-HI; Roche Molecular Biochem-
ical, Indianapolis, IN) into the main pancreatic duct, the distended pancreas is
cut into several pieces and put in a temperature-controlled chamber (“diges-
tion” step) that allows progressive heating up to 37°C. To allow for better
pancreas fragmentation, the chamber is agitated using the hand-shaking
technique. The digested pancreas is collected by centrifugation and washed
(“washing” step) before density gradient purification. At that stage, the
preparation contains fragmented exocrine tissue with 1–2% free intact islets.
The tissue suspension is then purified over a continuous-density gradient
using a COBE 2991 cell processor (“purification” step). The islet number is
determined following dithizone staining and is expressed as the number of
islet equivalents (1 islet equivalent 150-m diameter islet). The purity of the
human islet preparations used in this study was 70%. The human subjects
exemption code from the institutional review board is 0307M50821.
Human islet culture. Purified human islets are kept in culture in CMRL-1066
medium (Mediatech, Herndon, VA) supplemented with 10% heat inactivated
FBS (Mediatech) for a period of 2 days (37°C for 12–24 h and 28°C for 24–36
h) in a 5% CO2–humidified atmosphere. Cultured islets are treated for 45 min
with recombinant human interleukin-1 (IL-1) alone or in combination with
recombinant human tumor necrosis factor- (TNF) and recombinant human
-interferon (IFN) (each used at 10 ng/ml). All cytokines were purchased
from R&D systems (Minneapolis, MN).
Islet cell lysis and Western blotting experiments. Human islets are
washed once in cold PBS and recovered by centrifugation. Briefly, cell pellets
are dislodged into cold lysis buffer (20 mmol/l Tris-acetate, pH 7.0, 0.27 mol/l
sucrose, 1 mmol/l EDTA, 1 mmol/l EGTA, 50 mmol/l sodium fluoride, 1%
Triton X-100, 10 mmol/l -glycerophosphate, 1 mmol/l dithiothreitol [DTT], 10
mmol/l p-nitrophenylphosphate, and antiproteases) and the cells sonicated for
20 s and centrifuged at 15,000g for 20 min. The supernatants are recovered and
stored at 	70°C until use. Total protein in cell lysates is quantified by the
Bradford method (Bio-Rad Bioassay Kit). Equal quantity of total protein
lysates are resolved by 4–20% gel SDS-PAGE (Invitrogen) and electroblotted
onto polyvinylidine fluoride membranes. The blots are then probed with
primary antibodies for MKK7, MKK4 (1/2,000; Upstate), phospho-MKK4,
MKK3, phospho-MKK3/6, p38, phospho-p38, IB (1/1,000; Cell Signaling), and
tubulin (1/1,000, Santa Cruz). The secondary antibodies are used at 1/3,500
(Bio-Rad). Immunoblots are visualized using an enhanced chemiluminescence
detection system (Amersham Life Sciences).
Protein kinase assays and gel quantification. Islet protein extracts (40 g)
are incubated for 3 h at 4°C with 1 g of the fusion proteins glutathione
S-transferase (GST)–c-Jun and GST-Elk1 coupled with glutathione beads.
After centrifugation (2,000g for 2 min), the supernatant is removed and the
beads washed twice. The pellets are then resuspended in 20 l kinase buffer
(20 mmol/l HEPES, pH 7.5, 20 mmol/l -glycero-phosphate, 10 mmol/l MgCl2,
and 1 mmol/l DTT) and incubated with 1 l [-32P] ATP (3,000 Ci/mmol)
(Amersham) at 30°C for 30 min. The reactions are terminated by addition of
1
 Laemmli sample buffer (50 mmol/l Tris HCl, pH 6.8, 2% SDS, 100 mmol/l
DTT, 0.1% bromophenol blue, amd 10% glycerol). Phosphorylation of substrate
proteins is examined after SDS-PAGE (Bio-Rad). The gels are exposed
overnight to autoradiography and quantified by Phosphor-Imager analysis.
Measure of mRNA expression by real-time RT-PCR. Total RNA is isolated
from human pancreata using a commercial Kit (RNeasy Mini-kit protocol;
Qiagen) and quantified by spectrophotometry. Two micrograms of RNA are
reverse transcribed to cDNA (1 h at 37°C and 5 min at 95°C) using random
primers (Gibco-BRL). We applied a quantitative real-time RT-PCR technique
to measure gene expression. This method has been described in detail (see
manufacturer literature: Light Cycler; Roche Molecular Biochemicals). The
PCR uses the following primers: c-Fos: sense 5-TGATACACTCCAAGCGGA
GAC-3 and antisense 5-CCCAGTCTGCTGCATAGAAGG-3; insulin: sense
5-GTGCGGGGAACGAGGCTTCTTC-3 and antisense 5-GCGGCGGGTGTGG
GGCTGCC-3; iNOS: sense 5-ACGTGCGTTACTCCACCAACA-3 and anti-
sense 5-CATAGCGGATGAGCTGAGCA-3; and finally the housekeeping gene
-actin: sense 5-AACGGCTCCGGCATGTGCAA-3 and antisense 5-AGTACA
TCGCTGTGCACGTGGT-3.
Aliquots of the generated cDNAs (200 ng) are loaded into capillary tubes
and amplified for 40 cycles. The PCR products are further analyzed by agarose
gel electrophoresis to confirm the correct length of the amplified products.
Electrophoretic mobility shift assays. The assays are performed using two
annealed complementary synthetic oligonucleotides for NF-B binding (pur-
chased from Promega): NF-B: sense 5-AGCTAGCTTCAGAGGGGACTTTCC
GAGAGG-3 and antisense 5-AGCTCCTCTCGGAAAGTCCCCTCTGAAGCT-
3. The double-stranded oligonucleotide (4 pmol) is end labeled with [-32P]
ATP (3,000 Ci/mmol) (Amersham). Nuclear protein extracts are prepared from
human purified islets that were lysed as described above for kinase assays.
Following centrifugation, the nuclear pellets are resuspended in 100 l
high-salt buffer (20 mmol/l HEPES, pH 7.9, 1 mmol/l EDTA, 1 mmol/l MgCl2, 10
mmol/l KCl, 20% glycerol, 1 mmol/l DTT, 400 mmol/l NaCl, and antiproteases).
Protein concentration is determined by the Bradford method. For EMSAs,
10 g nuclear extract are incubated for 30 min on ice with the labeled probe
in EMSA binding buffer (100 mmol/l HEPES, pH 7.9, 50 mmol/l NaCl, 5 mmol/l
MgCl2, 5 mmol/l EDTA, 50% glycerol, and 5 mmol/l DTT). Poly (d1-dC) (1
g/l) is used as an unspecific DNA competitor in each reaction. Specific and
unspecific competitor oligonucleotides are incubated with the nuclear ex-
tracts on ice for 15 min before addition of the probe. DNA-protein complexes
are resolved on a 6% nondenaturing polyacrylamide gel in 1
 Tris-borate-
EDTA buffer (44 mmol/l Tris-HCl, pH 8.0, 44 mmol/l boric acid, and 1 mmol/l
EDTA, pH 8.0). Gels are fixed for 10 min (10% methanol and 10% acetic acid)
and dried for 40 min at 80°C. NF-B DNA binding activity is visualized by
autoradiography.
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TUNEL assays. Isolated human islets are washed in PBS, collected by
centrifugation, and added to 2% agarose gel. Cryostat sections are then used
for TUNEL assay according to the manufacturer’s instructions (In Situ Cell
Death Detection Kit, POD; Roche Boehringer Mannheim). The kit uses an
anti-fluorescein antibody conjugated to peroxidase.
Statistics. We analyzed pancreas and islet specimens from nine different
deceased human multiorgan donors. In each case, the purity of human islet
preparations was between 66 and 70%. All experiments were performed a
minimum of three times (i.e., with three different donors) in duplicate. For
some experiments, all nine donors were examined (i.e., n  3–9 for all data).
All results are presented as a means  SD. Statistical analysis for multiple
comparisons was determined by one-way ANOVA (post hoc comparisons,
Scheffe´ test). The differences found between the experimental groups were
considered statistically significant at P  0.05 or P  0.01.
RESULTS
MAPK level: activity of JNK, p38, and ERK during
islet isolation and in response to cytokines. We first
measured the activities of the three MAPKs JNK, p38, and
ERK at each main step of the islet isolation process and
following cytokine treatment. Samples were collected
from pancreas following tissue digestion, after the wash-
ing step, and at the end of the procedure with purified
islets. Cultured islets were also incubated with or without
cytokines, before protein and RNA extraction.
Activity of JNK was low in pancreas and became pro-
gressively higher during the isolation procedure. JNK
activity in total pancreatic extracts (98% exocrine tis-
sues) increased markedly (fivefold) following digestion
and after the wash step (sevenfold) (Fig. 1). This high level
of activity persisted up to the end of the isolation proce-
dure (purified islets). JNK activity then declined to a low
baseline level over 2 days of culture. Short-term exposure
of the cultured islets to the cytokine IL-1 alone increased
JNK activity to the same high level as during the isolation
process. Addition of the three cytokines in combination
(IL-1, TNF, and IFN) did not enhance JNK activity
further than IL-1 alone (data not shown).
p38 activity was already high in pancreas and persisted
throughout the procedure up to the actual islet purifica-
tion. p38 activity decreased after 48 h of culture. In
contrast to JNK, p38 did not appear to respond markedly
to IL-1 stimulation, but nevertheless, activation appeared
significant (Fig. 1). Finally, ERK activity was relatively
unaffected throughout the isolation procedure (Fig. 1).
ERK is not a bona fide stress pathway (28,39); however, it
provides an internal control in these experiments.
Collectively, these data indicate that the isolation pro-
cess is as potent in activating JNK as IL-1 alone or the
mix of cytokines IL-1, TNF, and IFN. However, the
procedure appears to be a more potent inducer of p38
activity than cytokines. It is remarkable to note that the
isolation procedure leads to a sustained activation of the
two stress kinases throughout all steps of isolation, lasting
well over several hours. This certainly has profound
implication for cell survival and function (45).
Downstream of MAPKs: induction of c-fos mRNA.
C-fos expression is under the control of a wide variety of
stimuli and many signaling pathways, with the three
MAPKs probably playing a dominant role in many cell
types. In -cell lines, c-fos is under the direct control of
JNK, whose activation appears necessary for its expres-
sion (20). Increased c-fos mRNA expression was detected
in digested and washed tissues, with maximal levels
reached at the end of purification (Fig. 2). After 2 days of
culture, c-fos returned to a low basal level. Surprisingly,
acute cytokine treatment (45 min) did not induce c-fos
expression despite a marked activation of JNK and a slight
FIG. 1. Effect of the islet isolation procedure and IL-1 stimulation on
activation of JNK, ERK, and p38. A: Representative experiments. For
measuring JNK and ERK activities, we used GST-Jun (JNK) and
GST-Elk1 (ERK) as substrates, as described in RESEARCH DESIGN AND
METHODS. Photographs represent 33P-phosphorylation of the sub-
strates (P-GSTs) following SDS-PAGE. The level of p38 phosphoryla-
tion was determined by immunobloting using an anti–P-p38 antibody,
and p38 levels were estimated using an anti-p38 antibody for normal-
ization. B: Quantification of data in A (arbitrary units). JNK activity:
n  5, P < 0.01 for purified versus cultured islets; P < 0.05 for IL-1
(IL-1)-treated versus cultured islets. Differences are also significant
with P < 0.01 for all data compared with TLM. p38 activity: n  5, P <
0.01 for digested, washed, and purified preparations versus cultured
islets; P < 0.05 between IL-1–treated versus cultured islets. ERK
activity: n 5, no significant difference was found among all groups.,
total pancreatic tissues (mainly exocrine, >98%); ■, purified endo-
crine tissues (>70%); , purified islets incubated with cytokines.
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activation of p38 in these conditions. As controls, neither
insulin nor actin mRNA levels appeared to be markedly
affected by these treatments (Fig. 2).
Upstream of JNK and p38: activation and recruitment
of MKK4, MKK7, and MKK3/6. Two JNK kinases (i.e.,
kinases able to activate JNK) have been described: MKK4
and -7. Biochemical studies indicated that in different cell
types, MKK7 is responsible for activation of JNK by
cytokines, whereas MKK4 responds to other stimuli like
irradiation, osmotic shocks, etc. MKK4 might also activate
p38, although this last activity is controversial (C. Wid-
mann, personal communication).
To determine which upstream pathways lead to JNK
activation during the isolation procedure versus cytokine
attack, we first determined the level of MKK7 expression
by Western blotting of the same extracts that we used for
measuring JNK activity (Fig. 1A). MKK7 appears equally
abundant in exocrine tissues and in purified islets imme-
diately following the isolation procedure (Fig. 3A). Re-
markably, MKK7 expression declined following islet
culture, reaching undetectable levels after 48 h. Neither
IL-1 nor the mix of cytokines (data not shown) appeared
to restore MKK7 expression. Due to the unavailability of
antibodies specifically recognizing the activated form of
MKK7 (phospho-MKK7), we were unable to correlate the
presence of MKK7 with its activation by the isolation
procedure. Nevertheless, these data indicate that whereas
MKK7 might transduce stress signaling to JNK during
human islet isolation, it certainly does not follow cytokine
attack, as the kinase does not appear to be expressed in
these conditions. In contrast to these observations, the
expression of MKK4 is not affected by either treatment
(Fig. 3A). However, phosphorylation (activation) of MKK4
is specifically detected when the islets are incubated with
cytokines, but not during isolation.
Next we investigated the implication of the upstream
p38 kinases MKK3 and -6 in inducing p38 phosphorylation
and activation during and after islet purification. Protein
extracts from human islets were immunoblotted with an
antibody recognizing both the phosphorylated forms of
MKK3 and -6 together, as well as with an antibody recog-
FIG. 2. Effect of islet preparation and cytokines stimulation on the
expression of the c-fos and insulin mRNAs. Human islets samples were
taken after each main step of islets isolation (pancreas, digestion,
wash, and purification). After culture (48 h), the cells were exposed
for 45 min to IL-1 (10 ng/ml) alone or in combination with the
cytokines TNF and IFN (10 ng/ml). Total RNAs were extracted and
RT-PCRs were performed as described in RESEARCH DESIGN AND METHODS.
Quantification of c-fos (top) and insulin gene expression (bottom) by
real-time RT-PCR (LightCycler). The -actin mRNA was used for
normalization. n  7, P < 0.01 when comparing c-fos mRNA expression
in cultured versus purified islets. No statistical differences were
observed between the cultured and IL-1 (IL-1)- and cyto-mix (Mix-
Cyto)-treated groups. , total pancreatic tissues (mainly exocrine,
>98%); ■, purified endocrine tissues (>70%); , purified islets incu-
bated with cytokines.
FIG. 3. Expression profile and activation of the upstream JNK kinases
MKK7 and -4 and of the upstream p38 kinases MKK3/6 during the islet
isolation procedure. Samples were taken during the main steps (pan-
creas, digestion, wash, and purification) of the isolation procedure and
then cultured for 48 h and treated with IL-1 for 45 min before Western
blot analysis. (A). The blots were probed with anti-MKK7 and anti–P-
MKK4. Results show the expression level of the MKK7 protein before
and after purification of islets, after islet culture, and following IL-1
stimulation. Equal protein loading was assessed by blotting mem-
branes with an antibody against tubulin. Blots were also probed with
an anti–P-MKK4 antibody to measure the activation of MKK4. The level
of total MKK4 (phosphorylated or not phosphorylated) was also
determined by Western blotting. Data represent the mean of four
independent experiments performed in duplicate. B: Total lysates
from human pancreata taken at the indicated steps were subjected to
Western blot analyses using a polyclonal antibody recognizing
both the phosphorylated forms of MKK3 (Ser189Thr193) and MKK6
(Ser207Thr211) simultaneously. Immunoblotting with an anti-MKK3
antibody was performed for normalization. Results are representative
of three independent experiments.
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nizing MKK3 alone (Fig. 3B). There are no marked changes
in the ratio between the activated forms of MKK3/6 and
expression of MKK3 during the first steps of the islets
isolation procedure (whole pancreas). There was no in-
crease in activity after purification and a 2.1-fold (P  0.05
relative to cultured islets) increase after cytokine treat-
ment. Collectively, whereas these results indicate that
neither MKK3 nor -6 mediate activation of p38 during
human islets isolation, two well-separated upstream path-
ways control JNK: cytokines specifically activate MKK4 in
the absence of MKK7, whereas the isolation procedure
recruits MKK7 only.
Recruitment of the NF-B–signaling pathway. NF-B
is probably a major factor that controls -cell death in
autoimmune diabetes. We thus studied the consequences
of islet isolation and cytokines on the activation of the
NF-B pathway by analyzing NF-B DNA-binding activity
in EMSA. NF-B was not detected immediately following
the isolation procedure, was apparent at 12 h of culture,
and reached maximum levels after 36 h. No NF-B DNA-
binding activity was detected after 48 h of culture (Fig.
4A). These data correlated with lower levels of the inhib-
itor I-B that increased at 48 h (data not shown).
Quantitative real-time PCR (LightCycler) was then used
to measure iNOS mRNA expression throughout the islet
isolation and after culture (Fig. 4B). iNOS expression was
not detected during the isolation process. However, iNOS
mRNAs were detected after 48 h of culture and persisted
for at least 4 days (data not shown). iNOS induction could
only marginally be further increased when islets were
treated for 1 h with the three cytokines, indicating that
iNOS expression following isolation reached levels com-
parable to those obtained after cytokine treatment.
High-level apoptosis following islet isolation. The
very marked activation of the JNK- and p38-signaling
pathways throughout the entire islet isolation procedure
suggested that significant islet apoptosis should be de-
tected at the end of the isolation process. Consistent with
this, we indeed detected a majority of freshly purified
islets staining positive in a TUNEL assay (Fig. 5). High
apoptosis following isolation was already described (46).
In contrast, none of the surviving islets after culture
showed high-level DNA fragmentation as measured in the
same assay. Note here that this isolation-induced apopto-
sis must be independent of iNOS expression (whose
mRNA is not detected immediately after purification). In
contrast, human islets treated with IL-1, in conditions
that gave maximal activation of JNK (see above), did not
show any significant sign of apoptosis (data not shown).
DISCUSSION
Islet transplantation has shown promise as a method to
restore glucose homeostasis in type 1 diabetic patients
(6,47). However, successful transplantation is limited by
the availability of human islets and by a high loss of islets
during isolation and following transplantation: up to 50%
of the infused islet mass may be destroyed through apo-
ptotic and other nonimmune inflammatory pathways, lead-
ing to graft failure (7). One of the critical factors in islet
transplantation is early graft failure, which is defined as
the immediate destruction of grafted islets (9,10). This
tendency of islet grafts to fail to function within a short
period after transplantation is termed PNF (48). These
drawbacks indicated that transplantation of a sufficient
number of islets, 6,000 islet equivalents/kg body wt (1
islet equivalent  150-m diameter islet), is an essential
condition for a successful graft (49). The high level of
-cell loss subsequent to isolation makes this number of
islets difficult to obtain from one single pancreas, making
until recently the use of “double-donor” transplants to
provide for an adequate therapeutic islet mass a prerequi-
site to successful grafting (50). Better pancreas preserva-
tion before islet transplantation remains therefore one of
the potential improvements to overcome islet shortage
and to improve PNF (46,51).
Isolation and purification expose islets to mechanical,
enzymatic, osmotic, and ischemic stresses, the precise
FIG. 4. Effect of the islet isolation procedure on NF-B DNA-binding
levels and iNOS mRNA expression. A: NF-B levels were assessed by
EMSA, as described in RESEARCH DESIGN AND METHODS. Left panel: Ex-
tracts were prepared from isolated islets at the indicated time points.
Right panel: Competition studies with the indicated excess of specific
(S) and nonspecific (NS) double-stranded oligonucleotides. Extracts
for competition studies were from islets at 36 h of culture (n  3). B:
Human islets samples were taken at each main step of isolation
(pancreas, digestion, wash, and purification). After culture (48 h),
cells were exposed for 45 min to IL-1 (IL-1; 10 ng/ml) alone or in
combination with the cytokines TNF and IFN (10 ng/ml). Total RNA
was extracted and RT-PCR performed as described in RESEARCH DESIGN
AND METHODS. The -actin mRNA was used as an internal control. The
illustration shown is representative of five experiments. , total
pancreatic tissues (mainly exocrine, >98%); ■, purified endocrine
tissues (>70%); , purified islets incubated with cytokines.
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consequences of which have been poorly characterized.
We have shown here that the isolation procedure and
cytokines recruit different stress-signaling pathways in
human islets. Whereas isolation recruits the MKK7 3
JNK/p38 3 c-fos and the NF-B 3 iNOS pathways,
cytokines activate an MKK4/MKK3/63 JNK/p38 pathway
without recruitment of c-fos. Given the established impor-
tance of the JNK/p38 3 c-fos and the NF-B 3 iNOS
pathways in the apoptosis of insulin-secreting cells in
experimental systems, these data indicate that islets sense
the isolation procedure as an important stress recruiting
the major proapoptotic intracellular pathways. It is also
likely that the isolation procedure together with cytokines
produced during the inflammatory process immediately
following transplantation may further synergize to en-
hance cell death (Fig. 6) (52). This might be achieved at
least partly through corecruitment of MKK7 by cytokines,
as it is possible that MKK7 may also transduce cytokine
signaling (as is the case in other cell types) (39).
The actual levels and activation states of the MAPK-
signaling components inside islets before the isolation
procedure are not clear from our data. This might be
addressed by immunohistochemistry studies with the rel-
evant antibodies, although data obtained in such a way are
only semiquantitative. In any case, we cannot rule out that
the JNK, p38, and NF-B pathways are already activated
prior to isolation. This seems, however, particularly un-
likely for the NF-B pathway, because we did not detect
any NF-B DNA-binding activity or iNOS expression at the
end of the isolation procedure. Both DNA-binding and
iNOS expression started after the completion of the pro-
cedure and were only transient. This strongly suggests that
this pathway has been specifically recruited by the isola-
tion procedure itself. Therefore, our data suggest that the
isolation process may play a role in promoting -cell
death, although this will need to be experimentally dem-
onstrated by using specific inhibitors of the JNK, p38, and
NF-B pathways. In contrast, in cultured islets, all of these
activities are markedly reduced, even though expression
of iNOS is elevated. We would therefore suggest that it
would be beneficial to culture islets before transplanta-
tion, probably in the presence of an iNOS inhibitor. The
high number of TUNEL-positive cells detected immedi-
ately after isolation indicates that many islets die following
processing. This suggests that only “nondamaged” islets
will survive after culture, whereas the TUNEL-positive
ones will ultimately disaggregate. This probably indicates
a high heterogeneicity of islet responses to stress events.
Our hope would be that the manipulation of the aforemen-
tioned pathways during the course of isolation would
decrease the number of TUNEL-positive islets at the end
of purification, thus allowing for more viable islets to be
transplanted.
In several cell systems, apoptosis necessitates a tran-
scriptional activity at least partly mediated by the induc-
tion of the c-fos and c-jun genes (42,53). In this study,
FIG. 5. TUNEL experiments. Purified is-
lets were processed for TUNEL assay ei-
ther immediately after isolation (left) or
following 2 days of culture (right). Frag-
mented nuclei stain brown in the assay.
Left: Examples of TUNEL-positive islets
immediately following isolation. No such
islets were detected after 48 h of culture.
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induction of c-fos has been observed only during isola-
tion, but not when cultured islets were “acutely” (45 min)
treated with IL-1 or with a mix of cytokines. Both
stresses recruited JNK to the same high level, but cyto-
kines recruited p38 less markedly. Specific retention of
JNK signaling in the cytoplasm has been already described
(54); our data indicate that this particular behavior might
be restricted to cytokine stresses. The absence of a marked
expression of c-fos by cytokines therefore appears to be
very specific for islets (including human islets). Assuming
that apoptosis of human islets probably requires, although
not demonstrated, at least some JNK- or p38-mediated
nuclear events (i.e., c-fos expression), we would hypothe-
size that any JNK- and/or p38-mediated apoptosis is pri-
marily elicited during the isolation procedure.
The upstream pathways leading to JNK activation also
appear to diverge depending on whether the initiating
stress is from isolation or cytokines: MKK7 probably
mediates JNK activation during isolation, whereas MKK4
is specifically recruited by cytokines. Both MKK4 and -7
are abundantly expressed in exocrine tissues and in puri-
fied islets. Remarkably, MKK7 becomes undetectable in
cultured islets. As MKK4 is not recruited during isolation,
specific expression of MKK7 in islets during the procedure
appears to be the crucial upstream mediator of JNK
activation. The expression of MKK7 after purification may
sensitize islets to cytokine attack (as described for other
cell systems) (34) if islets are to be transplanted immedi-
ately after isolation. This might increase damage of func-
tional islet mass and contribute to early graft failure and
PNF. Therefore, the observed downregulation of MKK7
expression might represent another extremely important
beneficial consequence of culturing islets before trans-
plantation.
The deleterious effect of NO on mediating -cell toxicity
prompted us to explore activation of NF-B, the major
transcription factor responsible for de novo transcription
of iNOS and concomitant elevated production of NO (55).
The combination of the three cytokines (IL-1, TNF, and
IFN) results in iNOS expression and increased produc-
tion of NO (56,57). Here, we found that the isolation
procedure results in a delayed accumulation of NF-B
DNA-binding activity, concomitant with an accumulation
of iNOS mRNA that was detected after 2 days of culture. In
our hands, iNOS expression seems equally potently in-
duced by the isolation procedure as by cytokines. How-
ever, because iNOS appeared to be expressed only well
after the completion of the isolation procedure, iNOS
probably does not play any significant role in the loss of
islets during, or immediately following, purification.
In summary, the major characterized stress pathways
known to mediate insulin-secreting cell death in animal
models appear to be sequentially activated from the earli-
est stages of the human islet isolation procedure until the
actual grafting. Pharmacological inhibition of the JNK,
p38, and NF-B pathways from the beginning of isolation
and throughout the transplantation procedure might prove
critical for the maintenance of islet cell mass and the
lowering of PNF (20–22), although this will need to be
experimentally demonstrated. This could probably be best
achieved through the use of cell-permeable peptides such
as the JNK inhibitor JNKI (20), which aims to block the
relevant pathways, as these molecules are able to remain
in the islets after grafting (S.A., B.J.H., C.B., unpublished
results). Our data would also strongly support the notion
that culturing islets before transplanting them might im-
prove survival through downregulation of the activity of
these pathways.
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